共 50 条
- [31] Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer MOLECULAR BIOMEDICINE, 2022, 3 (01):
- [32] Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target Amino Acids, 2017, 49 : 425 - 439
- [39] Development of potent and selective transglutaminase-2 inhibitors for the treatment of Huntington\'s disease ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242